ÇELTİKÇİ, B. Et Al. 2014. The role of JAK1/2-STAT3 as acute resistance mechanism to MEK inhibition in BRAF-mutant colorectal cancer cell lines.. JOURNAL OF CLINICAL ONCOLOGY , (Chicago) .

ÇELTİKÇİ, B., Carson, R., Johnston, P. G., & Van Schaeybroeck, S., (2014). The role of JAK1/2-STAT3 as acute resistance mechanism to MEK inhibition in BRAF-mutant colorectal cancer cell lines. . JOURNAL OF CLINICAL ONCOLOGY, Chicago

ÇELTİKÇİ, BAŞAK Et Al. "The role of JAK1/2-STAT3 as acute resistance mechanism to MEK inhibition in BRAF-mutant colorectal cancer cell lines.," JOURNAL OF CLINICAL ONCOLOGY, Chicago, 2014

ÇELTİKÇİ, BAŞAK Et Al. "The role of JAK1/2-STAT3 as acute resistance mechanism to MEK inhibition in BRAF-mutant colorectal cancer cell lines.." JOURNAL OF CLINICAL ONCOLOGY , Chicago, 2014

ÇELTİKÇİ, B. Et Al. (2014) . "The role of JAK1/2-STAT3 as acute resistance mechanism to MEK inhibition in BRAF-mutant colorectal cancer cell lines.." JOURNAL OF CLINICAL ONCOLOGY , Chicago.

@conferencepaper{conferencepaper, author={BAŞAK ÇELTİKÇİ Et Al. }, title={The role of JAK1/2-STAT3 as acute resistance mechanism to MEK inhibition in BRAF-mutant colorectal cancer cell lines.}, congress name={JOURNAL OF CLINICAL ONCOLOGY}, city={Chicago}, country={}, year={2014}}